Client profile
A pharmaceutical distribution company with state-owned enterprise heritage, founded 1952, 50+ years in drug and device distribution, 12 subsidiaries and 800+ employees. (Anonymized on legacy site.)
Challenges
- Inconsistent appraisal across subsidiaries
- Post-restructuring incentive redesign needed
- Large distribution network made front-line appraisal hard to enforce
Approach
- Group-level performance framework
- Differentiated metrics per subsidiary
- Cup-shaped KPI concepts for distribution roles (L1)
Results
Group performance system designed and rolled out across subsidiaries with unified, executable standards.
Real legacy-site project, anonymized.
